BindingDB logo
myBDB logout

BDBM93062 Vitamin D analog, 11::Vitamin D analog, 15

SMILES: C[C@@H](CCCCO)C1CCC2\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C(C)[C@H](O)C1

InChI Key: InChIKey=YZIQNNXLWCGZKG-IWDSJVCASA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 93062   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Vitamin D3 receptor


(Homo sapiens (Human))
BDBM93062
PNG
(Vitamin D analog, 11 | Vitamin D analog, 15)
Show SMILES C[C@@H](CCCCO)C1CCC2\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C(C)[C@H](O)C1 |r,wU:23.25,25.27,15.17,1.0,wD:21.23,@@:23,(-.69,7.62,;.08,6.29,;1.59,6.61,;2.62,5.46,;4.13,5.78,;5.16,4.64,;6.66,4.96,;-.39,4.82,;.51,3.58,;-.39,2.33,;-1.86,2.81,;-3.19,2.04,;-4.52,2.81,;-4.52,4.35,;-3.19,5.12,;-1.86,4.35,;-1.86,5.89,;-3.19,.5,;-4.52,-.27,;-4.52,-1.81,;-5.86,-2.58,;-5.86,-4.13,;-7.19,-4.9,;-4.52,-4.9,;-4.52,-6.44,;-3.19,-4.13,;-1.86,-4.9,;-3.19,-2.58,)|
Show InChI InChI=1S/C25H42O3/c1-17(7-4-5-14-26)21-11-12-22-20(8-6-13-25(21,22)3)10-9-19-15-23(27)18(2)24(28)16-19/h9-10,17-18,21-24,26-28H,4-8,11-16H2,1-3H3/b19-9-,20-10+/t17-,18?,21?,22?,23+,24+,25+/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
0.100n/an/an/an/an/an/an/an/a



University of Wisconsin-Madison



Assay Description
In vitro study, VDR binding assay were performed as previously described.


Bioorg Chem 47: 9-16 (2013)


Article DOI: 10.1016/j.bioorg.2013.01.001
BindingDB Entry DOI: 10.7270/Q2FX782T
More data for this
Ligand-Target Pair
Vitamin D3 receptor


(Homo sapiens (Human))
BDBM93062
PNG
(Vitamin D analog, 11 | Vitamin D analog, 15)
Show SMILES C[C@@H](CCCCO)C1CCC2\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C(C)[C@H](O)C1 |r,wU:23.25,25.27,15.17,1.0,wD:21.23,@@:23,(-.69,7.62,;.08,6.29,;1.59,6.61,;2.62,5.46,;4.13,5.78,;5.16,4.64,;6.66,4.96,;-.39,4.82,;.51,3.58,;-.39,2.33,;-1.86,2.81,;-3.19,2.04,;-4.52,2.81,;-4.52,4.35,;-3.19,5.12,;-1.86,4.35,;-1.86,5.89,;-3.19,.5,;-4.52,-.27,;-4.52,-1.81,;-5.86,-2.58,;-5.86,-4.13,;-7.19,-4.9,;-4.52,-4.9,;-4.52,-6.44,;-3.19,-4.13,;-1.86,-4.9,;-3.19,-2.58,)|
Show InChI InChI=1S/C25H42O3/c1-17(7-4-5-14-26)21-11-12-22-20(8-6-13-25(21,22)3)10-9-19-15-23(27)18(2)24(28)16-19/h9-10,17-18,21-24,26-28H,4-8,11-16H2,1-3H3/b19-9-,20-10+/t17-,18?,21?,22?,23+,24+,25+/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
50n/an/an/an/an/an/an/an/a



University of Wisconsin-Madison



Assay Description
In vitro study, VDR binding assay were performed as previously described.


Bioorg Chem 47: 9-16 (2013)


Article DOI: 10.1016/j.bioorg.2013.01.001
BindingDB Entry DOI: 10.7270/Q2FX782T
More data for this
Ligand-Target Pair